Aptose Biosciences, Inc. (APTO) Financials

APTO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 20.9 million 13.1 million
2023-06-30 26.6 million 12.8 million
2023-03-31 39.3 million 13.3 million
2022-12-31 51.0 million 13.3 million

APTO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -10.5 million 599000
2023-06-30 -13.5 million 769000
2023-03-31 -11.3 million 1.9 million
2022-12-31 -8.6 million 861000

APTO Net Income

No data available :(

APTO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 17.7 million - 1.1 million
2023-06-30 23.3 million - 1.2 million
2023-03-31 35.7 million - 1.2 million
2022-12-31 47.0 million - 1.3 million

APTO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 6.5 million
2023-06-30 6.2 million
2023-03-31 6.2 million
2022-12-31 6.2 million

APTO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 19 8.3 million 3.4 million -
2023-06-30 29000 10.6 million 3.9 million -
2023-03-31 29000 8.8 million 5.3 million -
2022-12-31 16000 6.8 million 3.6 million -

APTO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 109590
2023-06-30 - 115504
2023-03-31 - 131009
2022-12-31 - 100151

APTO

Price: $1.21

52 week price:
0.36
6.60

Earnings Per Share: -7.72 USD

P/E Ratio: -0.27

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 268562

Ebitda: -2.7 million

Market Capitalization: 22.4 million

Links: